Related Experiment Video
Updated: Jun 11, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Patient-Reported Racial and Ethnic Disparities in Patients With Ulcerative Colitis: Results From the National Health
Sabree C Burbage1, Kathryn L Krupsky2, M Janelle Cambron-Mellott3
1Population Health Research, Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Ulcerative colitis (UC) patients with moderate/severe disease experience worse health-related quality of life and higher costs. Racial/ethnic disparities exist, with Hispanic patients showing unique employment challenges related to UC severity.
Area of Science:
- Gastroenterology
- Health Economics
- Health Services Research
Background:
- Ulcerative colitis (UC) is a chronic inflammatory condition impacting quality of life.
- Limited research exists on patient-reported and economic outcomes across UC severity and racial/ethnic groups.
Purpose of the Study:
- To assess sociodemographic, patient-reported, and economic outcomes in UC patients.
- To examine associations between UC severity, race/ethnicity, and health outcomes.
Main Methods:
- Cross-sectional study using National Health and Wellness Survey data (2018-2020).
- Multivariable analyses assessed UC severity and race/ethnicity impact on HRQoL, WPAI, HCRU, and costs.
- Included 1500 UC participants: 1150 non-Hispanic White, 99 non-Hispanic Black, 251 Hispanic.
Main Results:
- Moderate/severe UC linked to worse HRQoL, WPAI, HCRU, and higher medical costs than mild UC.
- Non-Hispanic Black participants reported better HRQoL; Hispanic participants reported higher HCRU and costs compared to non-Hispanic White participants.
- Race/ethnicity interacted with UC severity in predicting labor force participation.
Conclusions:
- Moderate/severe UC significantly worsens patient outcomes and increases healthcare utilization and costs.
- Racial/ethnic differences in HRQoL, employment, and economic burden are evident.
- Hispanic patients exhibit distinct patterns in how UC severity affects employment; further research is needed.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.